Evidence map›Paper›PMID 40917877›Full record

ArticleiScience2025

Human cerebral organoids model tumor initiation and infiltration in an autologous astrocyte-supported setting.

Esther Schickel, Tamara Bender, Leon Kaysan, Simone Hufgard, Margot Mayer, David R Grosshans, Christiane Thielemann, Insa S Schroeder

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Esther SchickelBiophysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Hessen, Germany.
Tamara BenderBiophysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Hessen, Germany.
Leon KaysanBiophysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Hessen, Germany.
Simone HufgardBioMEMS Lab, University of Applied Sciences Aschaffenburg, Aschaffenburg, Bayern, Germany.
Margot MayerBioMEMS Lab, University of Applied Sciences Aschaffenburg, Aschaffenburg, Bayern, Germany.
David R GrosshansDepartment of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Christiane ThielemannBioMEMS Lab, University of Applied Sciences Aschaffenburg, Aschaffenburg, Bayern, Germany.
Insa S SchroederBiophysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Hessen, Germany.

Funding

Determining the optimal ion and fractionation scheme for the treatment of GBM in a comprehensive human organoid modelR01CA256848 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GROSSHANS, DAVID R · 2021 to 2025
$2.3M
NCI NIH HHS R01 CA256848
6 · The paper itself

Abstract

Efforts to efficiently target brain tumors are constrained by the dearth of appropriate models to study tumor behavior toward treatment approaches as well as potential side effects to the surrounding normal tissue. We established a reproducible cerebral organoid model of brain tumorigenesis in an autologous setting by overexpressing

Indexed as

CancerDevelopmental neuroscienceExperimental models in systems biology

Identifiers

PMID40917877
PMCPMC12410359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.